Predictors of response to therapy with omalizumab in patients with severe allergic asthma – a real life study-Reference-Cited by-同舟云学术

Predictors of response to therapy with omalizumab in patients with severe allergic asthma – a real life study

Published:2017-04-28 Issue:6 Volume:129 Page:598-604
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Kallieri Maria¹,Papaioannou Andriana I.¹,Papathanasiou Evgenia¹,Ntontsi Polyxeni¹,Papiris Spyridon¹,Loukides Stelios¹

Affiliation:

1. 2nd Respiratory Medicine Department, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Greece

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2017.1321945

Reference34 articles.

1. Global Initiative for Asthma. GINA workshop report, Global strategy for Asthma Management and prevention. Revised 2016, Available from http://www.ginasthma.org 2016.

2. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy

3. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects.

4. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

2. Clinical Response Predictive Model for Omalizumab in Moderate-to-Severe Asthma Patients;International Journal of Clinical Practice;2024-05-04

3. Mepolizumab in children and adolescents with severe eosinophilic asthma not eligible for omalizumab: a single Center experience;Journal of Asthma;2024-01-24

4. Eosinophil to lymphocyte ratio may predict OCS reduction and change in quality of life (AQLQ) resulting from asthma biological treatment;Immunopharmacology and Immunotoxicology;2023-12-27

5. Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain;Open Respiratory Archives;2023-07